Metraipolis › archive › dc_686e5d266daf
Ex Vivo Traceability Platform for Phospholipoproteomic Formulations: Functional Evidence Without Clinical Exposure — Europe PMC PMID:41007664
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41007664
- DOI
- 10.3390/biomedicines13092101
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T07:36:00.781Z
- SHA-256 of the archived text
5892e6df0fc8d13493a99bba12e453210aa3fe5d0b35fddcd6f382421d073a79- Stable URL of this page
https://metraipolis.com/documento/dc_686e5d266daf
How to cite
Ex Vivo Traceability Platform for Phospholipoproteomic Formulations: Functional Evidence Without Clinical Exposure — Europe PMC PMID:41007664 — Europe PMC (en), https://europepmc.org/article/MED/41007664 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_686e5d266daf (Metraipolis archive dc_686e5d266daf, sha256 5892e6df0fc8d13493a99bba12e453210aa3fe5d0b35fddcd6f382421d073a79)
BibTeX
@misc{dc686e5d266daf,
title = {Ex Vivo Traceability Platform for Phospholipoproteomic Formulations: Functional Evidence Without Clinical Exposure — Europe PMC PMID:41007664},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41007664},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_686e5d266daf; sha256 5892e6df0fc8d13493a99bba12e453210aa3fe5d0b35fddcd6f382421d073a79},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41007664. Agents can read the archived copy with the MCP tool read_document.